Continuous RNA Manufacturing With Inline PAT and CQA Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current RNA manufacturing processes in the biopharmaceutical sector are batch-based, which are time-consuming, resource-intensive, and expensive, lacking integration and real-time monitoring systems necessary for continuous manufacturing.
Innovation Solution
A modular system comprising an in vitro transcription (IVT) apparatus, tangential flow filtration (TFF) apparatus, and chromatography apparatus, integrated with inline Process Analytical Technologies (PAT) tools and a Critical Quality Attributes (CQA) controller, enabling closed-loop control for continuous RNA manufacturing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If batch production methods are used for RNA manufacturing, then process control and quality assurance are simplified, but productivity is low and manufacturing time is long (1-2 months or more)
Solution Approach 1:
The patent implements continuous manufacturing processes where materials flow continuously through interconnected unit operations (bioreactor → clarification → chromatography → formulation) without batch interruptions. This eliminates the start-stop nature of batch processing, maintaining continuous production flow and significantly reducing manufacturing time from 1-2 months to a much shorter duration while improving productivity.
Solution Approach 2:
The continuous manufacturing system is divided into distinct modular unit operations (upstream processing, clarification, downstream purification, formulation) that can be independently optimized and controlled. Each module performs a specific function while maintaining continuous flow, allowing for targeted process control at each stage without requiring complete process reintegration.
2Loss of time
If continuous manufacturing processes are implemented, then productivity increases and manufacturing time decreases, but process integration complexity and real-time monitoring requirements increase
Solution Approach 1:
The patent incorporates real-time monitoring systems with feedback control mechanisms that continuously measure process parameters (flow rates, concentrations, purity) at each unit operation and automatically adjust process conditions to maintain optimal performance. This closed-loop control system simplifies the management of continuous manufacturing by providing automated real-time adjustments without requiring manual intervention for every parameter change.
Solution Approach 2:
The patent replaces manual batch-to-batch transfer operations with automated continuous flow systems using pumps, valves, and control systems. This substitution of mechanical batch operations with automated continuous control reduces the complexity of manual process integration while enabling real-time monitoring and adjustment of manufacturing parameters throughout the process.
3Ease of operation
If batch operations are used, then facility footprint is larger, but process gaps and human labor requirements are higher
Solution Approach 1:
The patent merges multiple batch operations (cell culture, clarification, purification, formulation) into a single integrated continuous manufacturing line where materials flow continuously through connected unit operations. This consolidation eliminates the need for separate batch processing areas and reduces facility footprint while simultaneously reducing human labor requirements by automating the continuous flow and eliminating manual transfer operations between batches.
Data Source
AI summary
The present invention provides apparatus, systems, and methods for continuous manufacturing of RNA utilizing in-line monitoring of the in vitro transcription reaction and related downstream processes, including chromatography and filtration processes.